Physician profile
Henry Hirsch
NPI 1750727665
$53,233.24
in general payments reported to CMS, 2019-2025
33 companies · $21K in 2025
The $21K reported for 2025 was more than what 97% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $477 · 2020: $1,233 · 2021: $2,179 · 2022: $4,051 · 2023: $13K · 2024: $12K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $34K · Food and Beverage: $7,855 · Travel and Lodging: $3,339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $34,100.00 |
| Food and Beverage | $7,854.97 |
| Travel and Lodging | $3,339.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $37,475.18 | 2020-2025 | Afx2 Bifurcated Endograft System, Endocross Device, Torus Stent Graft System |
| Cagent Vascular INC | $6,054.02 | 2023-2025 | Serrantor |
| Boston Scientific Corporation | $3,854.65 | 2020-2025 | Angiojet Ultra 5000a, Ekosonic, Peripheral Rotalink Plus |
| Cook Medical LLC | $919.84 | 2019-2025 | Zenith Spiral-Z, Cook, Rosen |
| Silk Road Medical, INC. | $828.88 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Bolton Medical INC | $579.46 | 2022-2025 | Treo Abdominal Stent-Graft System |
| Terumo Medical Corporation | $455.97 | 2021-2023 | Glidesheath Slender |
| Becton, Dickinson and Company | $423.64 | 2021-2024 | Lutonix Drug Coated Balloon |
| W. L. Gore & Associates, INC. | $413.19 | 2019-2025 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Penumbra, INC. | $281.98 | 2024-2025 | Penumbra System |
| Medtronic Vascular, INC. | $250.03 | 2020 | |
| Bard Peripheral Vascular, INC. | $243.75 | 2020-2022 | |
| Surmodics, INC. | $176.33 | 2024-2025 | Pounce Venous Thrombectomy System, Pounce Xl Thrombectomy |
| Medtronic, INC. | $163.84 | 2021-2025 | In.Pact Admiral, Venaseal, Hawkone |
| Janssen Pharmaceuticals, INC | $148.75 | 2021-2024 | Xarelto |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $146.48 | 2025 | Esprit |
| Cardiovascular Systems INC. | $129.27 | 2021-2022 | |
| Ethicon US, LLC | $119.45 | 2025 | Evarrest |
| Abbvie INC. | $74.34 | 2023-2025 | |
| Resmed Corp | $65.86 | 2023 | |
| Angiodynamics, INC. | $63.13 | 2022-2025 | Alphavac |
| Inari Medical, INC. | $60.48 | 2022 | |
| Solventum Corporation | $45.91 | 2025 | V.A.C.Ulta, Prevena |
| Biocomposites INC | $45.45 | 2021 | |
| Tactile Systems Technology INC | $37.32 | 2024 | Flexitouch Plus, Entre Plus |
| Kci USA, INC. | $37.10 | 2022-2023 | Prevena |
| Takeda Pharmaceuticals U.S.A., INC. | $25.40 | 2024 | Gattex |
| Siemens Medical Solutions USA, INC. | $23.90 | 2021 | |
| Shockwave Medical, INC | $21.80 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.74 | 2020 | |
| Lemaitre Vascular, INC. | $19.63 | 2022 | |
| Urgo Medical North America, LLC | $13.73 | 2024 | Urgoclean Ag |
| Integra Lifesciences Corporation | $12.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Hirsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.